Published in Blood Weekly, May 13th, 2010
"There is an acute need for therapeutic developments because of the poor prognosis of these diseases. Since the knowledge of molecular genetics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-05-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.